Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 10;10(1):e23452.
doi: 10.1016/j.heliyon.2023.e23452. eCollection 2024 Jan 15.

Unlocking the potential of phenyl boronic acid functionalized-quercetin nanoparticles: Advancing antibacterial efficacy and diabetic wound healing

Sobia Abid  1 , Nuzhat Sial  1 , Muhammad Hanif  2 , Hafiz Muhammad Usman Abid  2 , Amna Ismail  1 , Hanniah Tahir  3
Affiliations

Unlocking the potential of phenyl boronic acid functionalized-quercetin nanoparticles: Advancing antibacterial efficacy and diabetic wound healing

Sobia Abid et al. Heliyon. .

Retraction in

Abstract

This study investigates the novel application of Phenyl Boronic Acid Functionalized-Quercetin nanoparticles (PBA-Qt NPs) in the context of antibacterial and diabetic wound healing. The research reveals a multifaceted approach, encompassing physicochemical characterization, antioxidant activity, antibacterial potential, and wound healing efficacy. The purpose of the study was to improve wound healing and antibacterial effects of quercetin and its esterified nanoparticles with phenyl boronic acid (PBA-Qt) compared with phenytoin streptozotocin-induced diabetic rats as a model. PBA-Qt NPs were confirmed using TLC, SEM, and FTIR. They exhibited superior DPPH scavenging (84.2 ± 0.12 %) compared to PBA (59.00 ± 0.18 %) and quercetin (79.02 ± 0.17 %). PBA-Qt showed significant antimicrobial properties with ZOI against Gram-negative (30.34 ± 0.02) and Gram-positive bacteria (25.40 ± 0.03). The MIC for Pseudomonas aeruginosa was 1.41 ± 0.03 μg/100 μL, and for Staphylococcus aureus, it was 8.25 ± 0.02 μg/100 μL. The MBC against Pseudomonas aeruginosa was 4.33 ± 0.02 μg/100 μL, and for Staphylococcus aureus, it was 8.25 ± 0.02 μg/100 μL. PBA-Qt NPs reduced MIC for both Gram-positive and Gram-negative bacteria compared to quercetin. They enhanced wound healing by 60-99 % in infected diabetic rats, outperforming phenytoin. PBA-Qt NPs stimulated angiogenesis, tissue repair, and regeneration, improving wound closure. In diabetic and non-diabetic wounds, PBA-Qt NPs demonstrated superior wound contraction and granulation tissue formation. In conclusion, PBA-Qt nanoparticles are promising for treating diabetic chronic wounds due to reduced irritation and enhanced antibacterial and wound-healing properties.

Keywords: Diabetes mellitus; Diabetic wounds; PBA-Qt nanoparticles; Wistar rats.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Image 1
Graphical abstract
Fig. 1
Fig. 1
SEM analysis of PBA-Qt nanoparticles.
Fig. 2
Fig. 2
Fourier transform infrared spectrum of ointment containing PBA-Qt nanoparticles.
Fig. 3
Fig. 3
Antioxidant activities of ointment containing PBA-Qt nanoparticles.
Fig. 4
Fig. 4
Skin irritation test evaluation of PBA-Qt gel-induced skin irritability.
Fig. 5
Fig. 5
Fasting blood glucose levels of diabetic rats Mean ± S.D (n = 3 for each group). **p ≤ 0.01.
Fig. 6
Fig. 6
Wound Healing Potential of PBA-Qt nanoparticles in Streptozotocin-Induced diabetic rats.
Fig. 7
Fig. 7
Wound contraction. Mean ± S.D (n = 3 for each group). **p ≤ 0.01.
Fig. 8
Fig. 8
Weight of wet and dry granulation Mean ± S.D (n = 3 for each group). **p ≤ 0.01.
Fig. 9
Fig. 9
Histological image examination of the hematoxylin−eosin (HE) stained tissues of groups of the rats (Yellow arrows shows fibroblasts while black arrows show epidermis). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
See this image and copyright information in PMC

References

    1. Wang S., Yan C., Zhang X., Shi D., Chi L., Luo G., Deng J. Antimicrobial peptide modification enhances the gene delivery and bactericidal efficiency of gold nanoparticles for accelerating diabetic wound healing. Biomater. Sci. 2018;6(10):2757–2772. - PubMed
    1. Davies M.J., Aroda V.R., Collins B.S., Gabbay R.A., Green J., Maruthur N.M., Rosas S.E., Del Prato S., Mathieu C., Mingrone G. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American diabetes association (ada) and the European association for the study of diabetes (EASD) Diabetes Care. 2022;45(11):2753–2786. - PMC - PubMed
    1. Akhtar S., Nasir J.A., Abbas T., Sarwar A. Diabetes in Pakistan: a systematic review and meta-analysis. Pakistan J. Med. Sci. 2019;35(4):1173. - PMC - PubMed
    1. Holl J., Kowalewski C., Zimek Z., Fiedor P., Kaminski A., Oldak T., Moniuszko M., Eljaszewicz A. Chronic diabetic wounds and their treatment with skin substitutes. Cells. 2021;10(3):655. - PMC - PubMed
    1. Baig M.S., Banu A., Zehravi M., Rana R., Burle S.S., Khan S.L., Islam F., Siddiqui F.A., Massoud E.E.S., Rahman M.H. An overview of diabetic foot ulcers and associated problems with special emphasis on treatments with antimicrobials. Life. 2022;12(7):1054. - PMC - PubMed

Publication types

LinkOut - more resources